CD133 has also been identified on the surface of cancer cells with stem cell like properties in many tumors including ovarian, liver, brain, prostate, colon, hepatocellular and lung cancer (Glumac and Lebeau, 2018). The gene discussed is PROM1; the disease is cancer.